Created and Supported by the Airway and Swallowing Committee of the American Academy of Otolaryngology-Head and Neck Surgery
- Noah P. Parker, MD, Indiana University
- Bradley A. Schiff, MD, Montefiore Medical Center
- Mark A. Fritz, MD, University of Kentucky
- Sarah K. Rapoport, MD, Georgetown University
- Sam Schild, MD, State University of New York-Downstate
- Kenneth W. Altman, MD, Geisinger Health System
- Albert L. Merati, MD, University of Washington
- Maggie A. Kuhn, MD, University of California-Davis
To establish tracheotomy recommendations that focus on patient and health care team well-being during the COVID-19 pandemic with minimization of risk, viral exposure, and personal protective equipment (PPE) depletion. This document is meant to provide background, considerations and recommendations based on an evolving body of literature and front-line information from this early stage in the pandemic. These recommendations may require individualization based on region, facility, resources, and patient-specific factors.
Studies from colleagues in China have shown that most of those who become critically ill with COVID-19 do so because of rapid progression of pneumonia to acute respiratory distress syndrome, which can lead to respiratory failure and death.1-5
The benefits of performing early tracheotomy in critically ill COVID-19 patients are unclear from available data. Based on the SARS-1 outbreak with a similar coronavirus, the need for mechanical ventilation was associated with a 46% mortality.6
As an aerosol generating procedure (AGP), tracheotomy increases potential viral exposure to the health care team,7 who require adequate PPE8,9 which is already a scarce resource.
Reducing the risk of nosocomial outbreak amplification through transmission of COVID-19 to other patients and health care workers is of critical importance.5
- The ability to wean sedation can reduce sedation-related delirium, improve patient comfort, and progress toward spontaneous ventilation trials that may impact ventilator shortages.
- Post-intubation laryngotracheal stenosis is well known risk of prolonged intubation, but has not been shown to be significantly reduced in patients treated with early tracheotomy in systematic reviews (typically less than 10 days).10,11
- In general, duration of mechanical ventilation has the potential to be significantly shortened with early tracheotomy and result in significantly shorter intensive care unit stays.12
- Incidence of ventilator-associated pneumonia, and overall mortality are not clearly improved with early tracheotomy.13-17
Risks of tracheotomy in COVID-19 positive patients
- As will all AGP, there is increased infectious risk to the surgical team due to aerosolized viral particles which can transmit for up to 3 hours, perhaps more.18
- There is also increased potential for virus exposure to the team who perform evaluations, suctioning, dressing changes and other post-tracheotomy care.
Timing of tracheotomy in COVID-19 positive ventilated patients
- There is no identified time-point when afflicted patients either improve, remain stable, or progress toward death due to pulmonary complications. In the SARS-1 epidemic, the mean time from onset to death was 23.7 days,19 suggesting low potential benefit of tracheotomy prior to this time.
- Patients who show no clinical or radiological remission within 10 days may be more likely to require ongoing ventilation and have a more severe course of disease, including death.5
- There is no anticipated timing for viral clearance, and critically ill patients may have significantly longer positive testing, lasting at least 2-3 weeks.4
- With increasing ability to test patients more quickly, patients with urgent and even emergent surgical needs may be able to be assessed for COVID-19 positivity.
- Sensitivity in viral testing is a concern, as suspected COVID-19 patients can have initial negative testing.20
- As outlined in the AAO-HNS statement of March 23, 2020, “Unless emergent, surgical procedures should only be undertaken after ascertaining the COVID-19 status”.
Resource allocation and personal protective equipment
- Multiple Otolaryngology-Head and Neck Surgery societies, including the AAO-HNS, have advised limiting care to time-sensitive and emergent problems with the routine use of appropriate PPE.21
- Use of PPE was shown to significantly reduce infection in healthcare providers during the SARS-1 epidemic.22
- Based on experiences with SARS-1 in 2003, 8,9 the University of Toronto, the Zhejian University School of Medicine, and Australian Society of Otolaryngology-Head and Neck Surgery have specified that N95 masks are necessary for COVID-19 positive or suspected patients undergoing airway surgery.
- Despite suggestions by the CDC that PPE can be reused, this practice is concerning and requires better data.
- Decision-making in tracheotomy should take into consideration the surgical and ICU team’s discretion as well as institutional policy.
- Avoid tracheotomy in COVID-19 positive or suspected patients during periods of respiratory instability or heightened ventilator dependence.
- Tracheotomy can be considered in patients with stable pulmonary status but should not take place sooner than 2-3 weeks from intubation and, preferably, with negative COVID-19 testing.
- Adhere to strict donning and doffing procedures based on institutional protocol.
- Limit the number of providers participating in tracheotomy procedure and post-procedure management.
- Perform entire tracheotomy procedure under complete paralysis.
- Rely on cold instrumentation and avoid monopolar electrocautery.
- Advance ETT and cuff safely below the intended tracheotomy site and hold respirations while incising trachea.
- Minimize tracheal suctioning during procedure to reduce aerosolization.
- Choose cuffed, non-fenestrated tracheostomy tube.
- Maintain cuff appropriately inflated post-operatively and attempt to avoid cuff leaks.
Avoid circuit disconnections and suction via closed circuit.
- Place a heat moister exchanger (HME) with viral filter or a ventilator filter once the tracheotomy tube is disconnected from mechanical ventilation.
- Delay routine post-operative tracheotomy tube changes until COVID-19 testing is negative.
- Yang, Xiaobo et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Resp Med 2020 (in press).
- Guan, Wei-Jie et al. Clinical Characteristics of Coronavirus Disease 2019 in China. New Eng J Med 2020 (in press).
- Wu, Chaomin et al. “Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.” JAMA internal medicine, e200994. 13 Mar. 2020.
- Chen, Jun et al. “Clinical progression of patients with COVID-19 in Shanghai, China.” The Journal of infection, S0163-4453(20)30119-5. 19 Mar. 2020.
- Murthy, Srinivas et al. “Care for Critically Ill Patients With COVID-19.” JAMA, 10.1001/jama.2020.3633. 11 Mar. 2020.
- Choi KW, Chau TN, Tsang O, et al. Outcomes and Prognostic Factors in 267 Patients with Severe Acute Respiratory Syndrome in Hong Kong. Ann Intern Med. 2003; 139:715-723.
- Patel ZM, Fernandez-Miranda J, Hwang PH, et al. PRECAUTIONS FOR ENDOSCOPIC TRANSNASAL SKULL BASE SURGERY DURING THE COVID-19 PANDEMIC. Neurosurgery, in press. 2020.
- Wei, William I et al. “Safe tracheostomy for patients with severe acute respiratory syndrome.” The Laryngoscope vol. 113,10 (2003): 1777-9.
- Kwan a. Fok WG, Law KI, et al. Tracheostomy in a patient with severe acute respiratory syndrome. Br J Anaesth 2004;92:280-2.
- Andriolo, Brenda N G et al. “Early versus late tracheostomy for critically ill patients.” The Cochrane database of systematic reviews vol. 1,1 CD007271. 12 Jan. 2015.
- Curry SD, Rowan PJ. Laryngotracheal Stenosis in Early vs Late Tracheostomy: A Systematic Review. Otolaryngol Head Neck Surg. 2020;162(2):160–167.
- Tong CCL, Kleinberger AJ, Paolino J, Altman KW. Tracheotomy Timing and Outcomes in the Critically Ill. Otolaryngology–Head and Neck Surgery 2012; 147(1) 44–51.
- Wang R, Pan C, Wang X, Xu F, Jiang S, Li M. The impact of tracheotomy timing in critically ill patients undergoing mechanical ventilation: A meta-analysis of randomized controlled clinical trials with trial sequential analysis. Heart Lung. 2019;48(1):46–54.
- Siempos, Ilias I et al. “Effect of early versus late or no tracheostomy on mortality and pneumonia of critically ill patients receiving mechanical ventilation: a systematic review and meta-analysis.” The Lancet. Respiratory medicine vol. 3,2 (2015): 150-158.
- Clec’h, Christophe et al. “Tracheostomy does not improve the outcome of patients requiring prolonged mechanical ventilation: a propensity analysis.” Critical care medicine vol. 35,1 (2007): 132-8.
- Combes, Alain et al. Is tracheostomy associated with better outcomes for patients requiring long-term mechanical ventilation? Critical care medicine 2007;35:802-7.
- Meng, Liang et al. “Early vs late tracheostomy in critically ill patients: a systematic review and meta-analysis.” The clinical respiratory journal vol. 10,6 (2016): 684-692.
- van Doremalen, Neeltje et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. New Eng J Med 2020
- Leung GM, Hedley AJ, Ho L-M, et al. The Epidemiology of Severe Acute Respiratory Syndrome in the 2003 Hong Kong Epidemic: An Analysis of All 1755 Patients. Ann Intern Med. 2004; 141:662-673.
- Ai T, Yang Z, Hou H et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology 2020.
- AAO-HNS Position Statement: Otolaryngologists and the COVID-19 Pandemic. https://www.entnet.org/content/aao-hns-position-statement-otolaryngologists-and-covid-19-pandemic, March 23, 2020 – 1:37pm
- Loeb, Mark et al. “SARS among critical care nurses, Toronto.” Emerging infectious diseases vol. 10,2 (2004): 251-5.
Revised April 2, 2020
Adopted March 27, 2020
Important Disclaimer Notice (Updated 7/31/14)
Position statements are approved by the American Academy of Otolaryngology–Head and Neck Surgery or Foundation (AAO-HNS/F) Boards of Directors and are typically generated from AAO-HNS/F committees. Once approved by the Academy or Foundation Board of Directors, they become official position statements and are added to the existing position statement library. In no sense do they represent a standard of care. The applicability of position statements, as guidance for a procedure, must be determined by the responsible physician in light of all the circumstances presented by the individual patient. Adherence to these clinical position statements will not ensure successful treatment in every situation. As with all AAO-HNS/F guidance, this position statement should not be deemed inclusive of all proper treatment decisions or methods of care, nor exclusive of other treatment decisions or methods of care reasonably directed to obtaining the same results. Position statements are not intended to and should not be treated as legal, medical, or business advice.